Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Tazawa

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Brain and Nerve = Shinkei Kenkyu No Shinpo|January 11, 2019
[Artificial Intelligence in Psychiatry]Akihiro Takamiya, Yuki Tazawa, Koki Kudo, et al.
Biological & Pharmaceutical Bulletin|July 14, 2012
Schedule-dependent cytotoxicity of etoposide (VP-16) and cyclophosphamide in leukemia cell line K-562Yuki Tazawa, Kazunori Matsumura, Yoh Takekuma, et al.
Biological & Pharmaceutical Bulletin|August 5, 2014
Schedule-dependent cytotoxicity of Etoposide and cyclophosphamide in P-glycoprotein-expressing human leukemic K-562 cellsYuki Tazawa, Ippei Usukubo, Kazuki Takada, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 31, 2023
Therapeutic Drug Monitoring of Oral Voriconazole in an Infant Less than Six Months of Age and Pharmacokinetics Changes Induced by Development of CYP2C19 in the Growth Process: A Novel Case ReportAtsushi Yamaguchi, Yuki Tazawa, Masashiro Ueki, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 3, 2018
[Evaluation of the Stability of Indomethacin Oral Spray in Two Different Formulation Conditions]Yuki Tazawa, Keisuke Kagami, Yuko Watanabe, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 4, 2018
[Possibility of Poor Outcomes after Treatment Using Teicoplanin at the Minimum Inhibitory Concentration of >2 μg/mL in Methicillin-resistant Staphylococcus aureus Bacteremia]Keisuke Kagami, Shungo Imai, Yuki Tazawa, et al.
Comprehensive Psychiatry|March 8, 2020
Evaluating the severity of depressive symptoms using upper body motion captured by RGB-depth sensors and machine learning in a clinical interview setting: A preliminary studyToshiro Horigome, Brian Sumali, Momoko Kitazawa, et al.
Journal of Pharmaceutical Health Care and Sciences|August 10, 2016
Pharmacokinetics and dose adjustment of etoposide administered in a medium-dose etoposide, cyclophosphamide and total body irradiation regimen before allogeneic hematopoietic stem cell transplantationYuki Tazawa, Akio Shigematsu, Kumiko Kasashi, et al.
Biological & Pharmaceutical Bulletin|May 16, 2018
Necessity for a Significant Maintenance Dosage Reduction of Voriconazole in Patients with Severe Liver Cirrhosis (Child-Pugh Class C)Takehiro Yamada, Shungo Imai, Yasuyuki Koshizuka, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 28, 2026
Perioperative pharmacokinetics of lenacapavir during massive hemorrhage in a patient with hemophilia a undergoing liver transplantationTomoyuki Endo, Yuki Tazawa, Toshihiro Matsukawa, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Brain and Nerve = Shinkei Kenkyu No Shinpo|January 11, 2019
[Artificial Intelligence in Psychiatry]Akihiro Takamiya, Yuki Tazawa, Koki Kudo, et al.
Biological & Pharmaceutical Bulletin|July 14, 2012
Schedule-dependent cytotoxicity of etoposide (VP-16) and cyclophosphamide in leukemia cell line K-562Yuki Tazawa, Kazunori Matsumura, Yoh Takekuma, et al.
Biological & Pharmaceutical Bulletin|August 5, 2014
Schedule-dependent cytotoxicity of Etoposide and cyclophosphamide in P-glycoprotein-expressing human leukemic K-562 cellsYuki Tazawa, Ippei Usukubo, Kazuki Takada, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 31, 2023
Therapeutic Drug Monitoring of Oral Voriconazole in an Infant Less than Six Months of Age and Pharmacokinetics Changes Induced by Development of CYP2C19 in the Growth Process: A Novel Case ReportAtsushi Yamaguchi, Yuki Tazawa, Masashiro Ueki, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 3, 2018
[Evaluation of the Stability of Indomethacin Oral Spray in Two Different Formulation Conditions]Yuki Tazawa, Keisuke Kagami, Yuko Watanabe, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 4, 2018
[Possibility of Poor Outcomes after Treatment Using Teicoplanin at the Minimum Inhibitory Concentration of >2 μg/mL in Methicillin-resistant Staphylococcus aureus Bacteremia]Keisuke Kagami, Shungo Imai, Yuki Tazawa, et al.
Comprehensive Psychiatry|March 8, 2020
Evaluating the severity of depressive symptoms using upper body motion captured by RGB-depth sensors and machine learning in a clinical interview setting: A preliminary studyToshiro Horigome, Brian Sumali, Momoko Kitazawa, et al.
Journal of Pharmaceutical Health Care and Sciences|August 10, 2016
Pharmacokinetics and dose adjustment of etoposide administered in a medium-dose etoposide, cyclophosphamide and total body irradiation regimen before allogeneic hematopoietic stem cell transplantationYuki Tazawa, Akio Shigematsu, Kumiko Kasashi, et al.
Biological & Pharmaceutical Bulletin|May 16, 2018
Necessity for a Significant Maintenance Dosage Reduction of Voriconazole in Patients with Severe Liver Cirrhosis (Child-Pugh Class C)Takehiro Yamada, Shungo Imai, Yasuyuki Koshizuka, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 28, 2026
Perioperative pharmacokinetics of lenacapavir during massive hemorrhage in a patient with hemophilia a undergoing liver transplantationTomoyuki Endo, Yuki Tazawa, Toshihiro Matsukawa, et al.
Pageof 2